CNIPA.AI
검색으로 돌아가기
기록

SUBSTITUTED PIPERIDINE COMPOUND AND USE THEREOF

발명심사 중
5조회수
21청구항 · 3 독립항
§ Ⅰ

개요

발명자

Tatsuhiko FUJIMOTO; Kentaro RIKIMARU; Koichiro FUKUDA; Hiromichi SUGIMOTO; Takahiro MATSUMOTO; Norihito TOKUNAGA; Mariko HIROZANE

IPC 분류

C7D 211/24A61P 25/C7D 211/36C7D 211/56C7D 213/30C7D 213/61C7D 213/74C7D 213/75C7D 215/44C7D 401/6C7D 401/12C7D 401/14C7D 405/6C7D 405/12C7D 405/14C7D 409/6C7D 409/12C7D 413/6C7D 417/6C7D 417/14

CPC 분류

C7D211/24A61P25/C7D211/36C7D211/56C7D213/30C7D213/61C7D213/74C7D213/75C7D215/44C7D401/6C7D401/12C7D401/14C7D405/6C7D405/12C7D405/14C7D409/6C7D409/12C7D413/6C7D417/6C7D417/14

Provided is a substituted piperidine compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as a prophylactic or therapeutic agent for narcolepsy.

원문 (중국어)

Provided is a substituted piperidine compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as a prophylactic or therapeutic agent for narcolepsy.